Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$69.00 USD

69.00
3,405,133

-0.70 (-1.00%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $68.91 -0.09 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Fresenius Medical to Make Huge Investments, Competition Rife

by Zacks Equity Research

Fresenius Medical (FMS) is likely to make huge investments in India and China.

AMN Healthcare Down on Soft Locum Tenens Business, Dull View

by Zacks Equity Research

Dependence on third parties is detrimental for AMN Healthcare (AMN).

BD Remains Confident About LUTONIX DCB Despite FDA Letter

by Zacks Equity Research

Per the recent press release issued by BD (BDX), it seems that the company still has immense confidence on the LUTONIX DCB.

DexCom (DXCM) Down 11.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HMS Holdings Gains on PI & TPM Solutions, Competition Rife

by Zacks Equity Research

HMS Holdings is consistently boosting margins and profitability on product-yield enhancements and process improvements.

    Here's Why You Should Retain Ecolab Stock in Your Portfolio

    by Zacks Equity Research

    A solid guidance for 2019 and broad product spectrum will provide Ecolab (ECL) a competitive edge in the MedTech space.

      DexCom, comScore, Lululemon, Nike and Under Armour highlighted as Zacks Bull and Bear of the Day

      by Zacks Equity Research

      DexCom, comScore, Lululemon, Nike and Under Armour highlighted as Zacks Bull and Bear of the Day

      Kevin Cook headshot

      Bull of the Day: DexCom (DXCM)

      by Kevin Cook

      Diabetes care goes beyond the finger prick to streaming digital data with this rapidly growing innovator

      Here's Why You Should Hold on to Cerner (CERN) Stock for Now

      by Zacks Equity Research

      Recently, Cerner (CERN) expanded its reach in the Alabama rural health care market through a new collaboration.

      Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

      by Zacks Equity Research

      Is (DXCM) Outperforming Other Medical Stocks This Year?

      Inogen's Prospects in Europe Solid Amid Trade-Related Tension

      by Zacks Equity Research

      Inogen's (INGN) business-to-business unit sees strength in Europe.

      Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4

      by Zacks Equity Research

      Veeva Systems' (VEEV) broad spectrum of products include Veeva Vault, Veeva CRM, Veeva Network and Veeva OpenData.

      Varian & Tata Trust Tie Up to Boost Radiotherapy in India

      by Zacks Equity Research

      Varian's (VAR) three-year deal with Tata Trust is likely to fortify its foothold in the Asia-Pacific radiotherapy space.

      The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

      by Zacks Equity Research

      The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

      Tirthankar Chakraborty headshot

      The Best And Worst Stocks of the 10-Year Bull Market

      by Tirthankar Chakraborty

      We highlight some of the best and worst stocks over the bull market's 10 years.

      HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick?

      by Zacks Equity Research

      DexCom (DXCM) looks stronger than Hologic (HOLX) when it comes to current-year earnings and revenue projections as well as fundamentals.

      Align Technology-Benco Dental Deal to Expand iTero Reach

      by Zacks Equity Research

      Align Technology (ALGN) adopts initiatives to boost top-line contributions from iTero Intraoral scanners.

      GNC Holdings to Expand Portfolio With Alani Nutrition Deal

      by Zacks Equity Research

      With Alani Nutrition being a women-focused supplement brand, it is believed that the partnership might help GNC Holdings (GNC) widen its customer base.

      Tandem's Global Growth a Boost, Operating Losses a Bane

      by Zacks Equity Research

      Tandem's (TNDM) t:slim X2 Insulin Pump clinching a commercial license in Canada during Q4 is a tailwind.

      GNC Forms Joint Venture With IVC to Improve Cost Efficiency

      by Zacks Equity Research

      The joint venture is set to manufacture the products produced by GNC Holdings' (GNC) Nutra manufacturing facility.

      Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now

      by Zacks Equity Research

      Hologic's (HOLX) management is impressed with continued growth in the core Molecular Diagnostics sub-segment.

      Hologic (HOLX) Receives Global Nods for Omni Hysteroscope

      by Zacks Equity Research

      Hologic's (HOLX) receipt of approvals for Omni Hysteroscope in Canada and Europe is expected to boost the GYN Surgical arm.

      Here's Why You Should Snap Up Abbott (ABT) Stock Right Now

      by Zacks Equity Research

      Synergies from Alere consolidation in the form of revenues from Abbott's (ABT) Rapid Diagnostics business have been driving growth.

      Here's Why You Should Invest in Chemed (CHE) Stock Right Now

      by Zacks Equity Research

      Chemed (CHE) sees revenue growth across its wholly-owned subsidiaries, VITAS Healthcare and Roto-Rooter. Its capital deployment policy is based on buyouts and solid return of cash to shareholders.

      DexCom (DXCM) Gets Health Canada Approval for G6 CGM System

      by Zacks Equity Research

      DexCom's (DXCM) G6 CGM system intends to serve diabetes patients of all age groups in Canada.